Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCθ inhibitors

被引:19
作者
Boschelli, Diane H. [1 ]
Subrath, Joan [1 ]
Niu, Chuansheng [1 ]
Wu, Biqi [1 ]
Wang, Yan [1 ]
Lee, Julie [2 ]
Brennan, Agnes [2 ]
Ho, Melisa [2 ]
Deng, Bijia [2 ]
Yang, Xiaoke [2 ]
Xu, Xin [3 ]
Leung, Louis [4 ]
Wang, Jianyao [4 ]
Atherton, James [4 ]
Chaudhary, Divya [2 ]
机构
[1] Wyeth Res, Pearl River, NY 10965 USA
[2] Wyeth Res, Inflammat, Cambridge, MA 02140 USA
[3] Wyeth Res, Drug Safety & Metab, Andover, MA 01810 USA
[4] Wyeth Res, Drug Safety & Metab, Collegeville, PA 19426 USA
关键词
Kinase; PKC theta; 3-Pyridinecarbonitrile; PROTEIN-KINASE-C; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VINYLBORONATE ESTER; ARYL HALIDES; AEB071; DELTA; MICE;
D O I
10.1016/j.bmcl.2010.01.119
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analog 8, a 3-pyridinecarbonitrile with an (E)-2-{6-[(4-methylpiperazin-1-yl) methyl]pyridin-2-yl} vinyl group at C-5, had an IC(50) value of 1.1 nM for the inhibition of PKC theta and potently blocked the production of IL-2 in both stimulated murine T cells (IC(50) = 34 nM) and human whole blood (IC(50) = 500 nM). (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1965 / 1968
页数:4
相关论文
共 21 条
[1]   PKC inhibitors: potential in T cell-dependent immune diseases [J].
Baier, Gottfried ;
Wagner, Juergen .
CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) :262-267
[2]   Small Molecule Inhibitors of PKCθ as Potential Antiinflammatory Therapeutics [J].
Boschelli, Diane H. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (07) :640-654
[3]  
CHAUDHARY D, UNPUB
[4]   Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCθ) inhibitors [J].
Cole, Derek C. ;
Asselin, Magda ;
Brennan, Agnes ;
Czerwinski, Robert ;
Ellingboe, John W. ;
Fitz, Lori ;
Greco, Rita ;
Huang, Xinyi ;
Joseph-McCarthy, Diane ;
Kelly, Michael F. ;
Kirisits, Matthew ;
Lee, Julie ;
Li, Yuanhong ;
Morgan, Paul ;
Stock, Joseph R. ;
Tsao, Desiree H. H. ;
Wissner, Allan ;
Yang, Xiaoke ;
Chaudhary, Divya .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) :5958-5963
[5]   NZB/NZW MICE AS A MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS [J].
DUBOIS, EL ;
HOROWITZ, RE ;
DEMOPOULOS, HB ;
TEPLITZ, R .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 195 (04) :285-+
[6]   The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation [J].
Evenou, Jean-Pierre ;
Wagner, Juergen ;
Zenke, Gerhard ;
Brinkmann, Volker ;
Wagner, Kathrin ;
Kovarik, Jiri ;
Welzenbach, Karl A. ;
Weitz-Schmidt, Gabriele ;
Guntermann, Christine ;
Towbin, Harry ;
Cottens, Sylvain ;
Kaminski, Sandra ;
Letschka, Thomas ;
Lutz-Nicoladoni, Christina ;
Gruber, Thomas ;
Hermann-Kleiter, Natascha ;
Thuille, Nikolaus ;
Baier, Gottfried .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03) :792-801
[7]   Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients [J].
Fujii, Y ;
Fujii, K ;
Tanaka, Y .
AUTOIMMUNITY REVIEWS, 2006, 5 (02) :143-144
[8]   HECK VERSUS SUZUKI PALLADIUM-CATALYZED CROSS-COUPLING OF A VINYLBORONATE ESTER WITH ARYL HALIDES [J].
HUNT, AR ;
STEWART, SK ;
WHITING, A .
TETRAHEDRON LETTERS, 1993, 34 (22) :3599-3602
[9]   T-cell fate and function:: PKC-θ and beyond [J].
Marsland, Benjamin J. ;
Kopf, Manfred .
TRENDS IN IMMUNOLOGY, 2008, 29 (04) :179-185
[10]   Protein kinase Cδ controls self-antigen-induced B-cell tolerance [J].
Mecklenbräuker, I ;
Saijo, K ;
Zheng, NY ;
Leitges, M ;
Tarakhovsky, A .
NATURE, 2002, 416 (6883) :860-865